Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F62PJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,050
Award facts
- Contract value 100% obligated
- $8,049.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on July 28, 2026, with a ceiling value of $8,049.93. The firm fixed-price order covers XELJANZ XR 11 MG tablets in 30-count unit-of-use packaging. Place of performance is Conshohocken, Pennsylvania, and the order was issued with no set-aside. The ultimate completion date is July 29, 2026. Amerisourcebergen Drug Corp is a wholly owned subsidiary of Cencora, Inc. and holds no SBA certifications.
Quick answers
Who was awarded contract SPE2DR26F62PJ?
SPE2DR26F62PJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 28, 2026.
How much is contract SPE2DR26F62PJ worth?
The government has obligated $8,050 on SPE2DR26F62PJ.
Is contract SPE2DR26F62PJ an order under another contract?
Yes. SPE2DR26F62PJ is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F62PJ competed?
The extent of competition for SPE2DR26F62PJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award